References
Dillaha CJ, Jansen GT, Honeycutt WM, Holt CA (1965) Further studies with topical 5-fluorouracil. Arch Dermatol 92:410–417
Du Vivier A, Stoughton RB (1975) An animal model for screening topical and systemic drugs for potential use in the treatment of psoriasis. J Invest Dermatol 65:235–237
Lowe NJ, Stoughton RB, McCullough JL, Weinstein GD (1981) Topical drug effects on normal and proliferating epidermal cell models. Arch Dermatol 117:394–398
Otani AS, Gange RW, Walter JF (1980) Epidermal DNA synthesis: a new disc technique for evaluating incorporation of tritiated thymidine. J Invest Dermatol 75:375–378
Sherertz EF, Sloan KB, McTiernan RG (1990) Transdermal delivery of 5-fluorouracil through skin of hairless mice and humans in vitro: a comparison of the effect of formulations and a prodrug. Arch Dermatol Res 282:463–468
Sloan KB, Bodor N (1982) Hydroxymethyl and acyloxymethyl prodrugs of theophylline: enhanced delivery of polar drugs through skin. Int J Pharm 12:299–313
Sloan KB, Sherertz EF, McTiernan RG (1988) The effect of structure of Mannich base prodrugs on their ability to deliver theophylline and 5-fluorouracil through hairless mouse skin. Int J Pharm 44:87–96
Stoll HL, Klein E, Case RW (1967) Tumors of the skin. VII. Effect of varying the concentration of locally administered 5-fluorouracil on basal cell carcinoma. J Invest Dermatol 49:219–224
Waranis RP, Sloan KB (1987) Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs. J Pharm Sci 76:587–595
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sloan, K.B., Sherertz, E.F. & McTiernan, R.G. The effect of 5-fluorouracil on inhibition of epidermal DNA synthesis in vivo: a comparison of the effect of formulations and a prodrug of 5-FU. Arch Dermatol Res 282, 484–486 (1990). https://doi.org/10.1007/BF00402629
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00402629